Share Price and Basic Stock Data
Last Updated: December 17, 2025, 10:01 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Puravankara Ltd operates within the construction and contracting industry, an essential sector as India continues to urbanize at a rapid pace. The company reported a market capitalization of ₹5,594 Cr, with its stock currently trading at ₹236. Revenue trends have been volatile, reflecting the cyclical nature of the real estate market. For instance, sales figures rose from ₹1,236 Cr in FY 2023 to ₹2,185 Cr in FY 2024, showcasing a significant rebound. However, the trailing twelve months (TTM) revenue stands at ₹1,880 Cr, indicating a potential slowdown in growth or seasonal fluctuations. The company’s quarterly results depict a mixed bag, with sales reaching a peak of ₹920 Cr in Mar 2024 before declining to ₹524 Cr by Jun 2025. Such fluctuations can be indicative of broader market trends or internal challenges, which investors should closely monitor.
Profitability and Efficiency Metrics
Profitability metrics for Puravankara Ltd present a concerning picture, particularly with a reported net profit of -₹266 Cr for the TTM period. This figure starkly contrasts with the net profit of ₹67 Cr in FY 2023, suggesting operational difficulties or increased costs that the company has faced recently. The operating profit margin (OPM) has also faced volatility, reported at 14% in FY 2025, down from 22% in FY 2022. Despite some improvements in the recent quarters, with OPM peaking at 34% in Dec 2023, the overall trend appears to be on a downward trajectory. Further complicating its profitability are the interest coverage ratios, which stood at a low 0.66x, indicating that the company struggles to cover its interest expenses, a significant red flag for potential investors.
Balance Sheet Strength and Financial Ratios
The balance sheet of Puravankara Ltd reveals a mixed picture, characterized by a total borrowing of ₹4,497 Cr against reserves of ₹1,500 Cr. This translates to a total debt-to-equity ratio of 2.48x, which is considerably high and suggests that the company is heavily leveraged. While this could amplify returns in a booming market, it also increases financial risk, particularly in a sector known for its cyclicality. The current ratio of 1.05x indicates that the company is just above the critical threshold of 1, suggesting it can cover its short-term liabilities, but barely. Investors should note that the return on equity (ROE) at 10% is relatively modest, reflecting the challenges in generating sufficient profits relative to shareholder equity. This balance sheet structure raises questions about the company’s capacity to sustain growth and manage debt effectively.
Shareholding Pattern and Investor Confidence
Puravankara Ltd’s shareholding pattern reflects a stable yet cautious investor base. Promoters hold 75% of the company, emphasizing strong insider confidence, which can often be reassuring for retail investors. However, foreign institutional investors (FIIs) hold approximately 17.23%, which shows a healthy interest from external parties, although this has seen slight fluctuations over recent quarters. Domestic institutional investors (DIIs) have a minimal stake of 0.49%, suggesting limited institutional backing. The number of shareholders has seen a decrease from 45,955 in Jun 2025 to 42,246 recently, hinting at potential investor fatigue or dissatisfaction with recent performance. This shift may signal declining confidence, which is critical for retail investors to consider when evaluating the stock’s future potential.
Outlook, Risks, and Final Insight
Looking ahead, investors should be aware of both the potential and the risks associated with Puravankara Ltd. The company’s strong promoter backing and recent revenue recovery could provide a foundation for growth, especially if it can manage its costs and improve profitability. However, the high debt levels, fluctuating sales, and negative net profits present significant risks that could dampen investor sentiment. Moreover, the cyclical nature of the real estate market means that external factors, such as interest rates and economic conditions, could heavily impact performance. Retail investors should weigh these factors carefully, considering both the potential for recovery and the challenges that lie ahead, as they make decisions about their investments in this construction giant.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Techindia Nirman Ltd | 20.1 Cr. | 14.0 | 34.8/13.8 | 7.54 | 0.00 % | 0.70 % | 7.32 % | 10.0 | |
| Tarmat Ltd | 133 Cr. | 52.2 | 86.4/45.0 | 43.6 | 72.9 | 0.00 % | 1.55 % | 0.92 % | 10.0 |
| Supreme Infrastructure India Ltd | 239 Cr. | 94.4 | 152/79.2 | 133 | 0.00 % | % | % | 10.0 | |
| SPML Infra Ltd – a Multi-sector Infrastructure Player | 1,334 Cr. | 177 | 323/136 | 27.2 | 112 | 0.00 % | 8.91 % | 7.78 % | 2.00 |
| SKIL Infrastructure Ltd | 25.1 Cr. | 1.16 | 5.26/1.06 | 2.82 | 8.93 | 0.00 % | 1.10 % | 4.76 % | 10.0 |
| Industry Average | 6,688.43 Cr | 211.93 | 44.57 | 108.04 | 0.04% | 6.53% | 9.16% | 7.10 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 215 | 239 | 392 | 389 | 323 | 368 | 574 | 920 | 658 | 496 | 318 | 542 | 524 |
| Expenses | 158 | 195 | 283 | 373 | 260 | 283 | 378 | 808 | 528 | 384 | 302 | 511 | 458 |
| Operating Profit | 57 | 45 | 110 | 16 | 63 | 85 | 196 | 112 | 130 | 112 | 16 | 30 | 67 |
| OPM % | 26% | 19% | 28% | 4% | 19% | 23% | 34% | 12% | 20% | 23% | 5% | 6% | 13% |
| Other Income | 82 | 13 | 18 | 91 | 13 | 13 | 22 | 27 | 18 | 32 | 17 | 22 | 14 |
| Interest | 88 | 76 | 94 | 102 | 98 | 105 | 105 | 127 | 119 | 141 | 143 | 152 | 161 |
| Depreciation | 4 | 4 | 5 | 4 | 5 | 6 | 7 | 10 | 7 | 8 | 8 | 11 | 10 |
| Profit before tax | 48 | -22 | 29 | 1 | -28 | -13 | 106 | 3 | 22 | -5 | -118 | -111 | -90 |
| Tax % | 28% | -22% | 22% | -2,093% | -36% | -13% | 27% | 352% | 31% | 257% | -22% | -21% | -24% |
| Net Profit | 34 | -17 | 23 | 27 | -18 | -11 | 78 | -7 | 15 | -17 | -93 | -88 | -69 |
| EPS in Rs | 1.45 | -0.72 | 0.95 | 1.12 | -0.75 | -0.47 | 3.29 | -0.28 | 0.64 | -0.71 | -3.90 | -3.62 | -2.85 |
Last Updated: August 20, 2025, 4:55 am
Below is a detailed analysis of the quarterly data for Puravankara Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 524.00 Cr.. The value appears to be declining and may need further review. It has decreased from 542.00 Cr. (Mar 2025) to 524.00 Cr., marking a decrease of 18.00 Cr..
- For Expenses, as of Jun 2025, the value is 458.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 511.00 Cr. (Mar 2025) to 458.00 Cr., marking a decrease of 53.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 67.00 Cr.. The value appears strong and on an upward trend. It has increased from 30.00 Cr. (Mar 2025) to 67.00 Cr., marking an increase of 37.00 Cr..
- For OPM %, as of Jun 2025, the value is 13.00%. The value appears strong and on an upward trend. It has increased from 6.00% (Mar 2025) to 13.00%, marking an increase of 7.00%.
- For Other Income, as of Jun 2025, the value is 14.00 Cr.. The value appears to be declining and may need further review. It has decreased from 22.00 Cr. (Mar 2025) to 14.00 Cr., marking a decrease of 8.00 Cr..
- For Interest, as of Jun 2025, the value is 161.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 152.00 Cr. (Mar 2025) to 161.00 Cr., marking an increase of 9.00 Cr..
- For Depreciation, as of Jun 2025, the value is 10.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 11.00 Cr. (Mar 2025) to 10.00 Cr., marking a decrease of 1.00 Cr..
- For Profit before tax, as of Jun 2025, the value is -90.00 Cr.. The value appears strong and on an upward trend. It has increased from -111.00 Cr. (Mar 2025) to -90.00 Cr., marking an increase of 21.00 Cr..
- For Tax %, as of Jun 2025, the value is -24.00%. The value appears to be improving (decreasing) as expected. It has decreased from -21.00% (Mar 2025) to -24.00%, marking a decrease of 3.00%.
- For Net Profit, as of Jun 2025, the value is -69.00 Cr.. The value appears strong and on an upward trend. It has increased from -88.00 Cr. (Mar 2025) to -69.00 Cr., marking an increase of 19.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is -2.85. The value appears strong and on an upward trend. It has increased from -3.62 (Mar 2025) to -2.85, marking an increase of 0.77.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:46 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,310 | 1,672 | 1,584 | 1,407 | 1,415 | 2,050 | 2,128 | 963 | 955 | 1,236 | 2,185 | 2,014 | 2,028 |
| Expenses | 835 | 1,287 | 1,244 | 998 | 1,110 | 1,612 | 1,681 | 681 | 746 | 1,006 | 1,730 | 1,723 | 1,811 |
| Operating Profit | 476 | 386 | 340 | 409 | 305 | 439 | 447 | 282 | 208 | 230 | 456 | 291 | 217 |
| OPM % | 36% | 23% | 21% | 29% | 22% | 21% | 21% | 29% | 22% | 19% | 21% | 14% | 11% |
| Other Income | 18 | 18 | 47 | 68 | 90 | 76 | 59 | 93 | 427 | 203 | 75 | 86 | 72 |
| Interest | 241 | 233 | 243 | 290 | 251 | 328 | 343 | 357 | 332 | 360 | 434 | 555 | 624 |
| Depreciation | 8 | 15 | 16 | 16 | 15 | 15 | 23 | 20 | 18 | 17 | 28 | 35 | 40 |
| Profit before tax | 244 | 156 | 128 | 171 | 129 | 172 | 140 | -2 | 286 | 55 | 68 | -212 | -376 |
| Tax % | 35% | 15% | 34% | 25% | 29% | 33% | 37% | 82% | 48% | -20% | 38% | -14% | |
| Net Profit | 160 | 133 | 83 | 129 | 91 | 114 | 88 | -4 | 148 | 67 | 42 | -183 | -292 |
| EPS in Rs | 6.75 | 5.60 | 3.49 | 5.44 | 3.85 | 4.82 | 3.73 | -0.17 | 6.22 | 2.80 | 1.78 | -7.59 | -12.13 |
| Dividend Payout % | 28% | 28% | 22% | 41% | 42% | 21% | 0% | 0% | 80% | 36% | 354% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -16.88% | -37.59% | 55.42% | -29.46% | 25.27% | -22.81% | -104.55% | 3800.00% | -54.73% | -37.31% | -535.71% |
| Change in YoY Net Profit Growth (%) | 0.00% | -20.72% | 93.02% | -84.88% | 54.73% | -48.08% | -81.74% | 3904.55% | -3854.73% | 17.42% | -498.40% |
Puravankara Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | -1% |
| 3 Years: | 28% |
| TTM: | -25% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -450% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 45% |
| 3 Years: | 39% |
| 1 Year: | -36% |
| Return on Equity | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 1% |
| 3 Years: | -1% |
| Last Year: | -10% |
Last Updated: September 5, 2025, 12:45 pm
Balance Sheet
Last Updated: December 4, 2025, 1:51 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 119 | 119 | 119 | 119 | 119 | 119 | 119 | 119 | 119 | 119 | 119 | 119 | 119 |
| Reserves | 2,055 | 2,142 | 2,165 | 2,248 | 2,275 | 1,738 | 1,795 | 1,777 | 1,923 | 1,868 | 1,765 | 1,612 | 1,500 |
| Borrowings | 1,697 | 1,793 | 2,172 | 2,067 | 2,379 | 2,895 | 2,670 | 2,835 | 2,627 | 2,944 | 3,325 | 4,332 | 4,497 |
| Other Liabilities | 869 | 1,109 | 1,090 | 1,814 | 2,011 | 3,973 | 3,487 | 3,697 | 3,955 | 5,125 | 6,518 | 8,169 | 9,219 |
| Total Liabilities | 4,739 | 5,163 | 5,546 | 6,247 | 6,783 | 8,725 | 8,071 | 8,429 | 8,623 | 10,055 | 11,727 | 14,232 | 15,335 |
| Fixed Assets | 92 | 112 | 88 | 114 | 125 | 128 | 122 | 111 | 96 | 107 | 163 | 232 | 233 |
| CWIP | 0 | 12 | 0 | 0 | 36 | 42 | 9 | 0 | 3 | 1 | 2 | 0 | 0 |
| Investments | 91 | 69 | 525 | 116 | 131 | 130 | 132 | 138 | 82 | 104 | 36 | 40 | 47 |
| Other Assets | 4,556 | 4,970 | 4,932 | 6,017 | 6,491 | 8,424 | 7,807 | 8,179 | 8,442 | 9,844 | 11,526 | 13,960 | 15,055 |
| Total Assets | 4,739 | 5,163 | 5,546 | 6,247 | 6,783 | 8,725 | 8,071 | 8,429 | 8,623 | 10,055 | 11,727 | 14,232 | 15,335 |
Below is a detailed analysis of the balance sheet data for Puravankara Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 119.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 119.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,500.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,612.00 Cr. (Mar 2025) to 1,500.00 Cr., marking a decrease of 112.00 Cr..
- For Borrowings, as of Sep 2025, the value is 4,497.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 4,332.00 Cr. (Mar 2025) to 4,497.00 Cr., marking an increase of 165.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 9,219.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8,169.00 Cr. (Mar 2025) to 9,219.00 Cr., marking an increase of 1,050.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 15,335.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 14,232.00 Cr. (Mar 2025) to 15,335.00 Cr., marking an increase of 1,103.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 233.00 Cr.. The value appears strong and on an upward trend. It has increased from 232.00 Cr. (Mar 2025) to 233.00 Cr., marking an increase of 1.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 47.00 Cr.. The value appears strong and on an upward trend. It has increased from 40.00 Cr. (Mar 2025) to 47.00 Cr., marking an increase of 7.00 Cr..
- For Other Assets, as of Sep 2025, the value is 15,055.00 Cr.. The value appears strong and on an upward trend. It has increased from 13,960.00 Cr. (Mar 2025) to 15,055.00 Cr., marking an increase of 1,095.00 Cr..
- For Total Assets, as of Sep 2025, the value is 15,335.00 Cr.. The value appears strong and on an upward trend. It has increased from 14,232.00 Cr. (Mar 2025) to 15,335.00 Cr., marking an increase of 1,103.00 Cr..
However, the Borrowings (4,497.00 Cr.) are higher than the Reserves (1,500.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 475.00 | 385.00 | 338.00 | 407.00 | 303.00 | 437.00 | 445.00 | 280.00 | 206.00 | 228.00 | 453.00 | 287.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 96 | 96 | 78 | 100 | 71 | 45 | 51 | 116 | 93 | 157 | 83 | 84 |
| Inventory Days | 1,328 | 1,718 | 6,990 | 3,052 | 2,438 | |||||||
| Days Payable | 145 | 155 | 658 | 211 | 216 | |||||||
| Cash Conversion Cycle | 96 | 1,279 | 1,641 | 100 | 6,403 | 2,886 | 2,273 | 116 | 93 | 157 | 83 | 84 |
| Working Capital Days | 425 | 372 | 536 | 502 | 410 | 180 | 153 | 488 | 580 | 322 | 32 | -27 |
| ROCE % | 13% | 9% | 9% | 10% | 8% | 10% | 10% | 8% | 13% | 7% | 10% | 6% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Basic EPS (Rs.) | -7.59 | 1.78 | 2.80 | 6.22 | -0.20 |
| Diluted EPS (Rs.) | -7.52 | 1.77 | 2.80 | 6.22 | -0.20 |
| Cash EPS (Rs.) | -6.50 | 3.25 | 2.21 | 7.18 | 0.76 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 73.19 | 79.67 | 84.05 | 86.38 | 80.49 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 73.19 | 79.67 | 84.05 | 86.38 | 80.49 |
| Revenue From Operations / Share (Rs.) | 84.91 | 92.14 | 52.11 | 40.26 | 40.51 |
| PBDIT / Share (Rs.) | 15.62 | 22.67 | 16.91 | 27.00 | 15.89 |
| PBIT / Share (Rs.) | 14.15 | 21.49 | 16.18 | 26.26 | 15.03 |
| PBT / Share (Rs.) | -9.21 | 3.18 | 1.02 | 12.27 | -0.01 |
| Net Profit / Share (Rs.) | -7.97 | 2.07 | 1.48 | 6.44 | -0.09 |
| NP After MI And SOA / Share (Rs.) | -7.58 | 1.78 | 2.80 | 6.22 | -0.19 |
| PBDIT Margin (%) | 18.39 | 24.60 | 32.44 | 67.08 | 39.22 |
| PBIT Margin (%) | 16.66 | 23.31 | 31.05 | 65.23 | 37.10 |
| PBT Margin (%) | -10.85 | 3.44 | 1.95 | 30.47 | -0.04 |
| Net Profit Margin (%) | -9.39 | 2.24 | 2.84 | 15.99 | -0.22 |
| NP After MI And SOA Margin (%) | -8.93 | 1.93 | 5.37 | 15.46 | -0.48 |
| Return on Networth / Equity (%) | -10.36 | 2.24 | 3.34 | 7.22 | -0.24 |
| Return on Capital Employeed (%) | 17.58 | 20.30 | 15.44 | 23.32 | 14.21 |
| Return On Assets (%) | -1.26 | 0.36 | 0.66 | 1.71 | -0.05 |
| Long Term Debt / Equity (X) | 0.06 | 0.30 | 0.23 | 0.28 | 0.28 |
| Total Debt / Equity (X) | 2.48 | 1.74 | 1.47 | 1.28 | 0.74 |
| Asset Turnover Ratio (%) | 0.15 | 0.20 | 0.13 | 0.10 | 0.08 |
| Current Ratio (X) | 1.05 | 1.12 | 1.19 | 1.30 | 1.24 |
| Quick Ratio (X) | 0.18 | 0.20 | 0.18 | 0.15 | 0.16 |
| Inventory Turnover Ratio (X) | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 353.52 | 178.36 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 212.48 | 141.82 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 0.00 | -253.52 | -78.36 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 0.00 | -112.48 | -41.82 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 0.66 | 1.24 | 1.11 | 1.93 | 1.06 |
| Interest Coverage Ratio (Post Tax) (X) | 0.65 | 1.11 | 1.10 | 1.46 | 0.99 |
| Enterprise Value (Cr.) | 9420.43 | 7334.08 | 4121.77 | 4843.19 | 2925.63 |
| EV / Net Operating Revenue (X) | 4.68 | 3.36 | 3.34 | 5.07 | 3.05 |
| EV / EBITDA (X) | 25.43 | 13.64 | 10.28 | 7.56 | 7.76 |
| MarketCap / Net Operating Revenue (X) | 2.91 | 2.28 | 1.25 | 2.65 | 1.74 |
| Retention Ratios (%) | 0.00 | -253.52 | -78.36 | 0.00 | 0.00 |
| Price / BV (X) | 3.37 | 2.64 | 0.77 | 1.24 | 0.87 |
| Price / Net Operating Revenue (X) | 2.91 | 2.28 | 1.25 | 2.65 | 1.74 |
| EarningsYield | -0.03 | 0.01 | 0.04 | 0.05 | 0.00 |
After reviewing the key financial ratios for Puravankara Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -7.59. This value is below the healthy minimum of 5. It has decreased from 1.78 (Mar 24) to -7.59, marking a decrease of 9.37.
- For Diluted EPS (Rs.), as of Mar 25, the value is -7.52. This value is below the healthy minimum of 5. It has decreased from 1.77 (Mar 24) to -7.52, marking a decrease of 9.29.
- For Cash EPS (Rs.), as of Mar 25, the value is -6.50. This value is below the healthy minimum of 3. It has decreased from 3.25 (Mar 24) to -6.50, marking a decrease of 9.75.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 73.19. It has decreased from 79.67 (Mar 24) to 73.19, marking a decrease of 6.48.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 73.19. It has decreased from 79.67 (Mar 24) to 73.19, marking a decrease of 6.48.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 84.91. It has decreased from 92.14 (Mar 24) to 84.91, marking a decrease of 7.23.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 15.62. This value is within the healthy range. It has decreased from 22.67 (Mar 24) to 15.62, marking a decrease of 7.05.
- For PBIT / Share (Rs.), as of Mar 25, the value is 14.15. This value is within the healthy range. It has decreased from 21.49 (Mar 24) to 14.15, marking a decrease of 7.34.
- For PBT / Share (Rs.), as of Mar 25, the value is -9.21. This value is below the healthy minimum of 0. It has decreased from 3.18 (Mar 24) to -9.21, marking a decrease of 12.39.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -7.97. This value is below the healthy minimum of 2. It has decreased from 2.07 (Mar 24) to -7.97, marking a decrease of 10.04.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -7.58. This value is below the healthy minimum of 2. It has decreased from 1.78 (Mar 24) to -7.58, marking a decrease of 9.36.
- For PBDIT Margin (%), as of Mar 25, the value is 18.39. This value is within the healthy range. It has decreased from 24.60 (Mar 24) to 18.39, marking a decrease of 6.21.
- For PBIT Margin (%), as of Mar 25, the value is 16.66. This value is within the healthy range. It has decreased from 23.31 (Mar 24) to 16.66, marking a decrease of 6.65.
- For PBT Margin (%), as of Mar 25, the value is -10.85. This value is below the healthy minimum of 10. It has decreased from 3.44 (Mar 24) to -10.85, marking a decrease of 14.29.
- For Net Profit Margin (%), as of Mar 25, the value is -9.39. This value is below the healthy minimum of 5. It has decreased from 2.24 (Mar 24) to -9.39, marking a decrease of 11.63.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -8.93. This value is below the healthy minimum of 8. It has decreased from 1.93 (Mar 24) to -8.93, marking a decrease of 10.86.
- For Return on Networth / Equity (%), as of Mar 25, the value is -10.36. This value is below the healthy minimum of 15. It has decreased from 2.24 (Mar 24) to -10.36, marking a decrease of 12.60.
- For Return on Capital Employeed (%), as of Mar 25, the value is 17.58. This value is within the healthy range. It has decreased from 20.30 (Mar 24) to 17.58, marking a decrease of 2.72.
- For Return On Assets (%), as of Mar 25, the value is -1.26. This value is below the healthy minimum of 5. It has decreased from 0.36 (Mar 24) to -1.26, marking a decrease of 1.62.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.06. This value is below the healthy minimum of 0.2. It has decreased from 0.30 (Mar 24) to 0.06, marking a decrease of 0.24.
- For Total Debt / Equity (X), as of Mar 25, the value is 2.48. This value exceeds the healthy maximum of 1. It has increased from 1.74 (Mar 24) to 2.48, marking an increase of 0.74.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.15. It has decreased from 0.20 (Mar 24) to 0.15, marking a decrease of 0.05.
- For Current Ratio (X), as of Mar 25, the value is 1.05. This value is below the healthy minimum of 1.5. It has decreased from 1.12 (Mar 24) to 1.05, marking a decrease of 0.07.
- For Quick Ratio (X), as of Mar 25, the value is 0.18. This value is below the healthy minimum of 1. It has decreased from 0.20 (Mar 24) to 0.18, marking a decrease of 0.02.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.03. This value is below the healthy minimum of 4. It has increased from 0.00 (Mar 24) to 0.03, marking an increase of 0.03.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 353.52 (Mar 24) to 0.00, marking a decrease of 353.52.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 212.48 (Mar 24) to 0.00, marking a decrease of 212.48.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has increased from -253.52 (Mar 24) to 0.00, marking an increase of 253.52.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has increased from -112.48 (Mar 24) to 0.00, marking an increase of 112.48.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 0.66. This value is below the healthy minimum of 3. It has decreased from 1.24 (Mar 24) to 0.66, marking a decrease of 0.58.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.65. This value is below the healthy minimum of 3. It has decreased from 1.11 (Mar 24) to 0.65, marking a decrease of 0.46.
- For Enterprise Value (Cr.), as of Mar 25, the value is 9,420.43. It has increased from 7,334.08 (Mar 24) to 9,420.43, marking an increase of 2,086.35.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.68. This value exceeds the healthy maximum of 3. It has increased from 3.36 (Mar 24) to 4.68, marking an increase of 1.32.
- For EV / EBITDA (X), as of Mar 25, the value is 25.43. This value exceeds the healthy maximum of 15. It has increased from 13.64 (Mar 24) to 25.43, marking an increase of 11.79.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.91. This value is within the healthy range. It has increased from 2.28 (Mar 24) to 2.91, marking an increase of 0.63.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has increased from -253.52 (Mar 24) to 0.00, marking an increase of 253.52.
- For Price / BV (X), as of Mar 25, the value is 3.37. This value exceeds the healthy maximum of 3. It has increased from 2.64 (Mar 24) to 3.37, marking an increase of 0.73.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.91. This value is within the healthy range. It has increased from 2.28 (Mar 24) to 2.91, marking an increase of 0.63.
- For EarningsYield, as of Mar 25, the value is -0.03. This value is below the healthy minimum of 5. It has decreased from 0.01 (Mar 24) to -0.03, marking a decrease of 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Puravankara Ltd:
- Net Profit Margin: -9.39%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 17.58% (Industry Average ROCE: 6.53%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -10.36% (Industry Average ROE: 9.16%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0.65
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.18
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 44.57)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 2.48
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -9.39%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Realty | No.130/1, Ulsoor Road, Bengaluru Karnataka 560042 | investors@puravankara.com http://www.puravankara.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ravi Puravankara | Chairman |
| Mr. Ashish Ravi Puravankara | Managing Director |
| Ms. Amanda Joy Puravankara | Whole Time Director |
| Mr. Anup Shah Sanmukh | Independent Director |
| Prof. Shailaja Jha | Independent Director |
| Mr. K G Krishnamurthy | Independent Director |
FAQ
What is the intrinsic value of Puravankara Ltd?
Puravankara Ltd's intrinsic value (as of 17 December 2025) is 83.60 which is 64.87% lower the current market price of 238.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 5,633 Cr. market cap, FY2025-2026 high/low of 445/205, reserves of ₹1,500 Cr, and liabilities of 15,335 Cr.
What is the Market Cap of Puravankara Ltd?
The Market Cap of Puravankara Ltd is 5,633 Cr..
What is the current Stock Price of Puravankara Ltd as on 17 December 2025?
The current stock price of Puravankara Ltd as on 17 December 2025 is 238.
What is the High / Low of Puravankara Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Puravankara Ltd stocks is 445/205.
What is the Stock P/E of Puravankara Ltd?
The Stock P/E of Puravankara Ltd is .
What is the Book Value of Puravankara Ltd?
The Book Value of Puravankara Ltd is 68.3.
What is the Dividend Yield of Puravankara Ltd?
The Dividend Yield of Puravankara Ltd is 0.00 %.
What is the ROCE of Puravankara Ltd?
The ROCE of Puravankara Ltd is 6.04 %.
What is the ROE of Puravankara Ltd?
The ROE of Puravankara Ltd is 10.0 %.
What is the Face Value of Puravankara Ltd?
The Face Value of Puravankara Ltd is 5.00.